再鼎医药首席商务官梁怡离职：朱彤接任大中华区新职位

和讯网04-22

快讯正文【再鼎医药商业化团队搭建者梁怡离任，朱彤接替首席商务官】再鼎医药宣布，前首席商务官兼大中华区总裁梁怡将于4月30日正式离职，其职责将由先声药业高级副总裁朱彤接替。朱彤的加入预示着再鼎医药在商业化道路上的全新布局。梁怡在任期间成功搭建了公司商业化团队，为再鼎医药的商业发展奠定基础。尽管再鼎医药未对此次人事变动提供详细理由，但梁怡的离任及朱彤的加入或将为公司带来新的商业策略与市场机遇。下载和讯...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2429923096?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-22 18:20","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2429923096","market":"us","top_or_hot":-1,"title":"再鼎医药首席商务官梁怡离职：朱彤接任大中华区新职位","media":"和讯网","content":"<div>\n<p>快讯正文【再鼎医药商业化团队搭建者梁怡离任，朱彤接替首席商务官】再鼎医药宣布，前首席商务官兼大中华区总裁梁怡将于4月30日正式离职，其职责将由先声药业高级副总裁朱彤接替。朱彤的加入预示着再鼎医药在商业化道路上的全新布局。梁怡在任期间成功搭建了公司商业化团队，为再鼎医药的商业发展奠定基础。尽管再鼎医药未对此次人事变动提供详细理由，但梁怡的离任及朱彤的加入或将为公司带来新的商业策略与市场机遇。下载和讯...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042220421087a170bf&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>再鼎医药首席商务官梁怡离职：朱彤接任大中华区新职位</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n再鼎医药首席商务官梁怡离职：朱彤接任大中华区新职位\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-22 18:20 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042220421087a170bf&s=b><strong>和讯网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>快讯正文【再鼎医药商业化团队搭建者梁怡离任，朱彤接替首席商务官】再鼎医药宣布，前首席商务官兼大中华区总裁梁怡将于4月30日正式离职，其职责将由先声药业高级副总裁朱彤接替。朱彤的加入预示着再鼎医药在商业化道路上的全新布局。梁怡在任期间成功搭建了公司商业化团队，为再鼎医药的商业发展奠定基础。尽管再鼎医药未对此次人事变动提供详细理由，但梁怡的离任及朱彤的加入或将为公司带来新的商业策略与市场机遇。下载和讯...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042220421087a170bf&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4531","symbol_name":"中概回港概念","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042220421087a170bf&s=b","article_id":"2429923096","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042220421087a170bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2429923096","pubTimestamp":1713781245,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"快讯正文【再鼎医药商业化团队搭建者梁怡离任，朱彤接替首席商务官】再鼎医药宣布，前首席商务官兼大中华区总裁梁怡将于4月30日正式离职，其职责将由先声药业高级副总裁朱彤接替。朱彤的加入预示着再鼎医药在商业化道路上的全新布局。梁怡在任期间成功搭建了公司商业化团队，为再鼎医药的商业发展奠定基础。尽管再鼎医药未对此次人事变动提供详细理由，但梁怡的离任及朱彤的加入或将为公司带来新的商业策略与市场机遇。下载和讯APP查看快讯，体验更佳>>","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4531":"中概回港概念","BK4548":"巴美列捷福持仓","BK4139":"生物科技","09688":"再鼎医药","BK4585":"ETF&股票定投概念","ZLAB":"再鼎医药","BK4526":"热门中概股","BK4588":"碎股"},"translate_title":"Zai Lab Chief Business Officer Liang Yi resigns: Zhu Tong takes over a new position in Greater China","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZLAB":1,"09688":0.9},"content_text":"快讯正文【再鼎医药商业化团队搭建者梁怡离任，朱彤接替首席商务官】再鼎医药宣布，前首席商务官兼大中华区总裁梁怡将于4月30日正式离职，其职责将由先声药业高级副总裁朱彤接替。朱彤的加入预示着再鼎医药在商业化道路上的全新布局。梁怡在任期间成功搭建了公司商业化团队，为再鼎医药的商业发展奠定基础。尽管再鼎医药未对此次人事变动提供详细理由，但梁怡的离任及朱彤的加入或将为公司带来新的商业策略与市场机遇。下载和讯APP查看快讯，体验更佳>>","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2429923096"}